 |
 |
JML Biopharm is currently developing innovative molecular imaging agents for early detection of serious diseases including cancers, brain disorders, and cardiovascular diseases.
We offer exciting opportunites for our investors. If you would like to receive JML Biopharm's information package by mail, please enter your information below. If you have a specific request, please enter it in the box.